1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
644F42470342964EB6525804B002439C3
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/44F42470342964EB6525804B002439C3!OpenDocument
18
19OpenDocument
203.235.188.113
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Document Excerpt: Developing Strong Medical Information Groups: Compliance, Activities & Resource Levels

DB Image

ID: MD-532


Features:

9 Info Graphics

12 Data Graphics

120 Metrics

2 Narratives


Pages/Slides: 4


Published: Pre-2018


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this complimentary excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study – click here

This excerpt includes research findings and metrics from document #5431 "Developing Strong Medical Information Groups: Compliance, Activities & Resource Levels”


Industries Profiled:
Pharmaceutical; Biopharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care


Companies Profiled:
Abbvie; Alnylam Pharmaceuticals; Astellas; AstraZeneca; Baxalta; Bayer; Boehringer Ingelheim; CSL Behring; Ferring Pharmaceuticals; Galderma; GW Pharmaceuticals; Incyte; Janssen; Lundbeck; Merck; Novartis; Neurocrine Biosciences; Pierre Fabre Medicament; ProStrakan; Pfizer; Sunovion; Teva Pharmaceutical Industries Ltd; Tillotts Pharma; Upsher-Smith; Xenoport

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.